drugset / Trial / NCT00436475

Vitamin D and Calcium Homeostasis for Prevention of Type 2 Diabetes

NCT00436475

RandomizedFactorialQuadruple-blindPrevention

Summary

The purpose of the randomized trial is to quantify the effect of vitamin D and calcium supplementation on beta-cell function, insulin sensitivity, glucose tolerance and systemic inflammation and other cardiometabolic outcomes in ambulatory adults at high risk for type 2 diabetes.

Timeline

Start
2007-09
Primary completion
2009-11
Completion
2009-11

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Calcium carbonate Other / unclassified 400 mg Oral
Subject Cholecalciferol Other / unclassified 2000 iu Oral